Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Everyone may be talking about the death of movie theaters, but here are the sleeper hit movies you may have missed in '25, and five not to miss in '26.
California Pizza Kitchen enters a new era as fresh investment fuels growth, innovation, and global expansion—showing how legacy restaurant brands stay relevant.